MEI Pharma, Inc. Business Finance Contracts & Agreements
59 Contracts & Agreements
- Equity Distribution Agreements (1 contract)
- Guarantee Agreements (1)
- Purchase Agreements (4)
- Registration Rights Agreements (9)
- Share Agreements (1)
- Stock Agreements (13)
- Subscription Agreements (8)
- Underwriting Agreements (5)
- Warrant Agreements (17)
- Description of MEI Common Stock (Filed With SEC on September 26, 2023)
- Form of Warrant (Filed With SEC on September 26, 2023)
- Underwriting Agreement, dated as of December 1, 2021, by and among the Company, Jefferies LLC, Stifel, Nicolaus & Company, Incorporated, and Wells Fargo Securities, LLC, as... (Filed With SEC on December 6, 2021)
- Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Filed With SEC on December 17, 2020)
- Description of Capital Stock of MEI Pharma, Inc (Filed With SEC on September 9, 2020)
- Underwriting Agreement, dated as of December 17, 2019, between the Company, Stifel, Nicolaus & Company, Incorporated and Wells Fargo Securities, LLC, as representatives of the... (Filed With SEC on December 18, 2019)
- Amended and Restated 2008 Stock Omnibus Equity Compensation Plan (Filed With SEC on November 30, 2018)
- Form of Warrant (incorporated by reference to Exhibit 10.1) (Filed With SEC on May 16, 2018)
- Registration Rights Agreement dated May 16, 2018, between MEI Pharma, Inc. and the purchasers identified in Exhibit A therein (Filed With SEC on May 16, 2018)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 2, 2016)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 4, 2015)
- MEI PHARMA, INC. (a Delawarecorporation) 10,000,000 Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on December 17, 2014)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 4, 2014)
- 4,375,000 Shares MEI PHARMA,INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on October 29, 2013)
- 2,030,000 Shares MEI PHARMA, INC. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 10, 2013)
- MEI PHARMA, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on March 29, 2013)
- WARRANT (Filed With SEC on November 5, 2012)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on November 5, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 5, 2012)
- ASSET PURCHASE AGREEMENT by and between MEI Pharma, Inc. as Purchaser, and S*BIO Pte Ltd. as Seller Dated as of August 7, 2012 Table of Contents (Filed With SEC on August 8, 2012)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 8, 2012)
- FORM OF SUBSCRIPTION AGENT AGREEMENT (Filed With SEC on March 20, 2012)
- MARSHALL EDWARDS, INC. FORM OF SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on March 20, 2012)
- FORM OF WARRANT AGREEMENT (Filed With SEC on March 20, 2012)
- SECURITIES SUBSCRIPTION AGREEMENT (Filed With SEC on December 29, 2011)
- MARSHALL EDWARDS, INC. AMENDED AND RESTATED 2008 STOCK OMNIBUS EQUITY COMPENSATION PLAN (Filed With SEC on December 5, 2011)
- FORM OF AMENDED AND RESTATED SERIES A WARRANT (Filed With SEC on September 29, 2011)
- FORM OF AMENDED AND RESTATED SERIES B WARRANT (Filed With SEC on September 29, 2011)
- SECURITIES SUBSCRIPTION AGREEMENT (Filed With SEC on September 29, 2011)
- MARSHALL EDWARDS, INC. NONQUALIFIED STOCK OPTION GRANT (Filed With SEC on June 2, 2011)
- AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 16, 2011)
- AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 16, 2011)
- FORM OF SERIES A WARRANT (Filed With SEC on May 16, 2011)
- FORM OF SERIES B WARRANT (Filed With SEC on May 16, 2011)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 2, 2011)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on May 2, 2011)
- [FORM OF SERIES [A][B][C] WARRANT] (Filed With SEC on May 2, 2011)
- STOCK PURCHASE AGREEMENT (Filed With SEC on March 18, 2011)
- MARSHALL EDWARDS, INC. Common Stock (par value $0.00000002 per share) At Market Issuance Sales Agreement (Filed With SEC on February 7, 2011)
- EX-4.1: WARRANT (Filed With SEC on July 30, 2008)
